Wed.Jan 08, 2025

article thumbnail

Questex’s International Beauty Show and International Esthetics, Cosmetics and Spa Conference Are Back with Expanded Offerings for 2025

Beauty Launchpad

The International Beauty Show (IBS New York) and the International Esthetics, Cosmetics, & Spa Conference (IECSC New York) will return to the Javits Convention Center March 23-25, 2025.

article thumbnail

Face & Body Returns To Silicon Valley for 2025

Skin Inc

Face & Body's loyal attendees asked us to return to Silicon Valley, and as Dorothy famously said, "there is no place like home," so Face & Body is going back to the Bay Area.

52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ASDSA Study Highlights Lack of On-site Physician Supervision in Las Vegas Medical Spas

The Dermatology Digest

Medical spas in Las Vegas, NV, lack on-site physician supervision, according to a study by the the American Society for Dermatologic Surgery Association (ASDSA). Of the 63 medical spas reviewed, 73% of treatments involving injections were performed by non-physicians. Many spas did not even have a physician on-site, and in cases of complications, they didnt inform an off-site medical director.

Medical 36
article thumbnail

BioStem Launches BR-AM-DFU Clinical Trial for Non-Healing Diabetic Foot Ulcers

Dermatology Times

The company is currently recruiting participants to demonstrate the benefits of its BioREtain technology.

Clinic 41
article thumbnail

Elizabeth Faye Is Making Wellness an Industry Standard

Beauty Launchpad

Certified Business and Trauma-informed Life Coach Elizabeth Faye dives into how her journey in the industry inspired her to launch several wellness initiatives to help beauty professionals feel their best and thrive.

40
article thumbnail

Milestone Alert: Last Patient Completes 1-year Follow-up in Phase 3 Study of Ameluz-PDT in sBCC

The Dermatology Digest

The last patient in Biofronteras Phase 3 study of Ameluz and RhodoLED PDT in superficial basal cell carcinoma (sBCC) completed their one-year follow-up visit in December of 2024. The double-blind, randomized, placebo-controlled, multi-center ALA-BCC-CT013 study evaluated safety and efficacy in 187 patients with one or more clinically and histologically confirmed superficial BCCs.

Safety 36

More Trending

article thumbnail

Exploring the Role of Topical ET-02 in Androgenic Alopecia

The Dermatology Digest

Eirion Therapeutics Inc.s topical ET-02 may be more effective than existing treatments for androgenic alopecia, according to results of a first-in-man clinical trial. ET-02 restores normal function to hair follicle stem cells that have become inactive in age-related hair loss due to a defect that develops in the stem cell biology. By correcting this defect and returning the stem cells to normal activity and function, the expectation is that hair growth can be restored.

Safety 36
article thumbnail

Ionic Liquids Boost Skin Drug Delivery

Dermatology Times

The innovative technology is unlocking new possibilities in dermatology by improving the solubility and permeability of drugs for topical use.

article thumbnail

8 Reasons Not To Sleep In Your Makeup

The Skin Institute

After a long day, a night out with the girls, or a date night, you may be tempted to crash into bed without removing your makeup. However, this can have negative effects on your skin and face such as breakouts, rashes, excessive oil, dull-looking skin, and more. While there are endless reasons to follow a strict skincare routine and not sleep in your makeup, we will only share a few here.

Makeup 52
article thumbnail

FDA Approves Collagen-Based DermiSphere Hydrogel

Dermatology Times

Designed to mimic natural tissue scaffolds, DermiSphere hDRT offers innovative support for cellular infiltration and healing in reconstructive surgery.

article thumbnail

Phase 2 Trial of Qtorin 3.9% Rapamycin Anhydrous Gel Underway in Patients With Cutaneous Venous Malformations

Dermatology Times

Palvella begins its phase 2 TOIVA trial of Qtorin rapamycin gel for cutaneous venous malformations, targeting the mTOR pathway.

36
article thumbnail

Combination Treatment of Cryolipolysis and Hyaluronic Acid Fillers Greatly Enhances Jawline

Dermatology Times

The synergistic approach reduced submental fullness, enhanced mandible line definition, and improved chin projection.

article thumbnail

Unveiling the Complexities of Atopic Dermatitis Care

Dermatology Times

Experts explore innovative therapies, psychosocial impacts, and education strategies for managing atopic dermatitis in a Dermatology Times video series.